|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,325.00 JPY | +1.16% |
|
-0.87% | -11.14% |
| 06-15 | Goldman Sachs Upgrades Chugai Pharmaceutical to Buy from Neutral; Price Target is 8,950 Yen | MT |
| 05-26 | Major Asian Stock Markets Fall Amid Renewed Middle East Tensions | MT |
| Market Cap | 12,055B 74.25B 64.89B 59.87B 55.19B 104B 7,150B 106B 716B 281B 3,502B 279B 273B | P/E 2026 * |
23.7x | P/E 2027 * | 20.3x |
|---|---|---|---|---|---|
| Enterprise Value | 11,133B 68.57B 59.92B 55.3B 50.97B 96.07B 6,603B 98.2B 661B 260B 3,234B 258B 252B | EV / Sales 2026 * |
8.02x | EV / Sales 2027 * | 7.09x |
| Free-Float |
38.12% | Yield 2026 * |
1.87% | Yield 2027 * | 2.15% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | +1.16% | ||
| 1 week | -0.87% | ||
| Current month | -2.77% | ||
| 1 month | -4.25% | ||
| 3 months | -12.26% | ||
| 6 months | -11.23% | ||
| Current year | -11.14% |
| 1 week | 7,105 |  | 7,350 |
| 1 month | 7,105 | | 7,939 |
| Current year | 7,105 | | 10,700 |
| 1 year | 5,942 | | 10,700 |
| 3 years | 3,922 | | 10,700 |
| 5 years | 3,191 | | 10,700 |
| 10 years | 1,003.33 | | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 01/03/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | 59 | 28/03/2024 |
Shinya Takuma
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Fumio Tateishi
BRD | Director/Board Member | 77 | 01/03/2023 |
Iwaaki Taniguchi
BRD | Director/Board Member | 59 | 28/03/2024 |
Hideo Teramoto
BRD | Director/Board Member | 66 | 01/03/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.16% | -0.87% | +5.85% | +89.18% | 74.25B | |
| +0.85% | -0.80% | +54.84% | +163.70% | 1,051B | |
| +1.23% | -1.53% | +55.26% | +59.07% | 609B | |
| +0.04% | +2.58% | +32.96% | +88.75% | 450B | |
| +0.78% | -0.71% | +30.04% | +24.61% | 330B | |
| +1.41% | +0.58% | +33.92% | +47.20% | 284B | |
| -0.27% | -1.87% | +22.13% | +23.47% | 263B | |
| -1.76% | +2.37% | -22.19% | -38.45% | 223B | |
| -1.42% | +0.80% | +22.81% | +60.77% | 198B | |
| -1.48% | +3.43% | +23.42% | +73.31% | 167B | |
| Average | +0.01% | +0.40% | +25.90% | +59.16% | 364.93B | |
| Weighted average by Cap. | +0.23% | +0.01% | +37.10% | +81.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,387B 8.55B 7.47B 6.89B 6.35B 11.97B 823B 12.24B 82.37B 32.4B 403B 32.09B 31.39B | 1,535B 9.46B 8.26B 7.62B 7.03B 13.25B 911B 13.54B 91.14B 35.85B 446B 35.51B 34.73B |
| Net income | 509B 3.13B 2.74B 2.53B 2.33B 4.39B 302B 4.49B 30.21B 11.88B 148B 11.77B 11.51B | 593B 3.65B 3.19B 2.94B 2.71B 5.12B 352B 5.23B 35.19B 13.84B 172B 13.71B 13.41B |
| Net Debt | -922B -5.68B -4.96B -4.58B -4.22B -7.96B -547B -8.13B -54.73B -21.53B -268B -21.33B -20.86B | -1,164B -7.17B -6.27B -5.78B -5.33B -10.04B -690B -10.27B -69.1B -27.18B -338B -26.92B -26.33B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | ¥7,325.00 | +1.16% | 2,964,200 |
| 16/07/26 | ¥7,241.00 | +1.59% | 2,301,400 |
| 15/07/26 | ¥7,128.00 | -1.56% | 2,330,400 |
| 14/07/26 | ¥7,241.00 | +0.15% | 1,973,600 |
| 13/07/26 | ¥7,230.00 | -2.15% | 2,054,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
